Trials / Completed
CompletedNCT05600283
Patient Self-sampling of HPV to Screen for Cervical Cancer
Validation and Feasibility of Patient Self-sampling of HPV for Cervical Cancer Screening
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 222 (actual)
- Sponsor
- Mayo Clinic · Academic / Other
- Sex
- Female
- Age
- 25 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to validate a patient self-sampling vaginal collection kit and laboratory testing for the detection of HPV (human papillomavirus) infection. Researchers will compare the laboratory results of self-collected vaginal swab samples to usual healthcare provider-collected cervical swab samples to determine the laboratory HPV testing accuracy of the self-collection swab.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIAGNOSTIC_TEST | Swab kit (COBAS HPV 4800 Assay -Evalyn brush) | Patient self-sampling swab kit to collect a vaginal sample for HPV testing |
| DIAGNOSTIC_TEST | Clinician-collection of cervical sample for HPV testing | Speculum exam and collection of a cervical specimen using standard endocervical brush and spatula placed into ThinPrep medium for HPV testing (Evalyn brush) |
Timeline
- Start date
- 2022-11-16
- Primary completion
- 2024-06-04
- Completion
- 2024-06-04
- First posted
- 2022-10-31
- Last updated
- 2026-01-06
- Results posted
- 2025-09-19
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT05600283. Inclusion in this directory is not an endorsement.